New antibacterials: breakthrough or me-too?
D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002437:Cefazolin / Q000627:therapeutic use; D002514:Cephapirin / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D006801:Humans; D013411:Sulfadiazine / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014031:Tobramycin / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D013411:Sulfadiazine; D000658:Amoxicillin; D002514:Cephapirin; D014295:Trimethoprim; D002437:Cefazolin; D013420:Sulfamethoxazole; D014031:Tobramycin